Related by context. All words. (Click for frequent words.) 69 oxycodone CR 66 anagrelide 66 del 5q MDS 66 ß blockers 66 combination antiretroviral therapy 66 TMP SMX 65 NNT = 65 hepatitis C genotype 65 tipranavir ritonavir 65 Hepatotoxicity 65 aldosterone antagonist 65 nonvertebral fracture 65 relapsed MM 65 BARACLUDE ® 64 Kivexa 64 Hb A1C 64 arterial thromboembolic events 64 SSRI SNRI 64 polytherapy 64 statistically significant predictor 64 postoperative atrial fibrillation 64 maximal doses 64 antiretroviral naive 64 comorbid ADHD 64 rimonabant #mg 64 containing abacavir 64 venous thromboembolic disease 64 APTIVUS r 64 ACTEMRA TM 64 untreated OSA 63 prolonged QT interval 63 CIMZIA TM certolizumab pegol 63 TEAEs 63 KETEK 63 tipranavir r 63 Nesiritide 63 overactive bladder symptoms 63 protease inhibitors PIs 63 nonadherence 63 antiretroviral naïve 63 HIV coinfected 63 opioid dependent 63 bupropion SR 63 varenicline Chantix 63 inhaled corticosteroids ICS 63 P. falciparum malaria 63 venlafaxine XR 63 Subgroup analyzes 63 dalteparin 63 baseline HbA1c 63 atypical antipsychotic medications 63 receiving ISENTRESS 63 PASI scores 63 beta carotene supplementation 63 null responder 63 headache abdominal pain 63 HIV lipodystrophy 63 recurrent venous thromboembolism 63 receiving VICTRELIS 63 Celsentri Selzentry 63 multivariate adjustment 63 ritonavir boosted lopinavir 63 transaminase elevations 63 EFFEXOR XR 63 abacavir lamivudine 63 receiving antiretroviral therapy 62 tapentadol ER 62 CYP#D# inhibitor 62 dapagliflozin plus 62 HBeAg negative patients 62 salmeterol fluticasone 62 antimuscarinic 62 β blocker 62 TDF FTC 62 herpes zoster vaccine 62 VaD 62 gemifloxacin 62 ARCALYST ® 62 microbiologically evaluable 62 receiving XGEVA 62 aromatase inhibitors AIs 62 coinfected patients 62 interferon ribavirin 62 ORENCIA ® 62 Betaferon R 62 β blockers 62 deep venous thromboses 62 lipid elevations 62 poor metabolizers 62 genital herpes infections 62 bronchial hyperresponsiveness 62 octreotide LAR 62 co trimoxazole 62 clomipramine 62 DAS# CRP 62 Isentress raltegravir 62 sotalol 62 severe exacerbations 62 revascularizations 62 doxorubicin docetaxel 62 hypovitaminosis D 62 recurrent VTE 62 inhaled bronchodilators 62 undetectable viral 62 nonsevere 62 opioid naïve 62 non cirrhotic portal 62 Chlamydia trachomatis infection 62 prospectively stratified 62 VTE prophylaxis 62 CP CPPS 62 rosuvastatin Crestor 62 ibandronate 62 protease inhibitor PI 62 Commonly prescribed 62 Cipralex ® 62 elevated ALT 62 chronic HBV 62 thrombocytopenic 62 chlamydial infection 62 MIRAPEX 62 mild renal insufficiency 62 SSRI antidepressant 61 HbA1C levels 61 neuro psychiatric disorders 61 LV dysfunction 61 statins cholesterol lowering 61 DVT PE 61 amoxicillin clavulanate 61 serum urate levels 61 glycated hemoglobin levels 61 Heavy menstrual bleeding 61 lipid lowering medications 61 OSAHS 61 Viral load 61 comorbid illnesses 61 oral antidiabetes 61 mcg BID 61 myocardial infarctions MIs 61 experienced virologic failure 61 lipid lowering agents 61 anticoagulant warfarin 61 glycated hemoglobin HbA1c 61 FluCAM arm 61 neutropenia febrile neutropenia 61 corticosteroid dose 61 Immune reconstitution syndrome 61 Infusion Reactions Severe 61 recurrent tonsillitis 61 Avandia Actos 61 acromegalic patients 61 solifenacin 61 severe asthma exacerbations 61 amisulpride 61 atherothrombotic disease 61 generalized anxiety disorder GAD 61 tiagabine 61 rFVIIa 61 thromboembolic disease 61 clinically evaluable patients 61 initiating antiretroviral therapy 61 Arranon 61 elevated serum creatinine 61 clinically evaluable 61 asymptomatic PAD 61 elevated triglyceride levels 61 tamoxifen Nolvadex ® 61 limiting generalizability 61 mania hypomania 61 symptomatic BPH 61 TMC# r 61 haloperidol Haldol 61 COPD exacerbation 61 polyp recurrence 61 recurrent glioblastoma multiforme 61 fatigue asthenia 61 indinavir 61 divalproex sodium 61 symptomatic VTE 61 prednisone prednisolone 61 HbA 1c levels 61 haematologic 61 recurrent UTI 61 abacavir Ziagen 61 HIV uninfected 61 squamous cell lung cancer 61 mcg kg REBETOL 61 topical calcineurin inhibitors 61 morphometric vertebral fractures 61 Captopril 61 nonvertebral fractures 61 #mg/day [001] 61 nonadherent 61 intravenous diuretics 61 hypoglycaemic episodes 61 postexposure prophylaxis 61 symptomatic hyponatremia 61 Platelet counts 61 postoperative AF 61 REYATAZ ® 61 darunavir r 61 elevated IOP 61 uncomplicated malaria 61 virological suppression 61 tegaserod 61 NATRECOR ® 61 MADRS score 61 premenstrual syndrome PMS 61 NATRECOR R 61 candidemia 61 sulphonylureas 61 psychotherapeutic drugs 61 ATACAND 61 potent antiretroviral therapy 61 agomelatine 61 inhaled budesonide 61 trimethoprim sulfamethoxazole 61 peginterferon alfa 61 postoperative infections 61 intracranial hemorrhage ICH 61 Stent thrombosis 60 ARIXTRA R 60 dual endothelin receptor antagonist 60 % CI #.#-#.# [008] 60 AGILECT R 60 CVD mortality 60 serologically active patients 60 perioperatively 60 DETROL LA 60 certolizumab 60 cytomegalovirus infection 60 de aths 60 digoxin toxicity 60 steroid dexamethasone 60 pentoxifylline 60 FROVA 60 lipohypertrophy 60 pyridostigmine 60 hepatorenal syndrome 60 acarbose 60 CPAP adherence 60 attain statistical significance 60 dyslipidaemia 60 uncontrolled hypertension 60 NIASPAN 60 HER2 overexpression 60 systemic corticosteroid 60 abnormal lipid levels 60 aspirin clopidogrel 60 venous thromboembolic events 60 carotid artery blockage 60 achieved ACR# 60 basiliximab 60 nevirapine Viramune 60 severe hypoglycaemia 60 COPD exacerbations 60 IOP lowering 60 antiemetics 60 acute respiratory tract infections 60 conventional DMARDs 60 nasopharyngitis headache 60 treat NNT 60 noncardiovascular mortality 60 detrusor overactivity 60 oxcarbazepine 60 sustained virological response 60 moderately emetogenic 60 R entecavir 60 unresectable HCC 60 HBeAg negative 60 OAB symptoms 60 prescription opioid 60 underdiagnosis 60 multivariable adjusted 60 eosinophilic asthma 60 flutamide 60 systemic hypotension 60 Hp2 2 60 ICD therapy 60 KRAS mutations occur 60 comorbid depression 60 antioxidant supplementation 60 Plaquenil 60 EXJADE 60 glomerular filtration 60 mcg QD 60 Paxil paroxetine 60 Effexor venlafaxine 60 mycophenolate mofetil MMF 60 elevated LDL cholesterol 60 somnolence dizziness 60 Lipitor #mg 60 Hypotension 60 ACE Inhibitors 60 ADHD stimulant 60 titrated glipizide 60 paroxetine sertraline 60 HeFH 60 psoriatic arthritis PsA 60 ALI ARDS 60 hormone receptor negative 60 nitrofurantoin 60 ALT flares 60 nonnucleoside reverse transcriptase inhibitors 60 Atomoxetine 60 asthma exacerbation 60 virologic failure 60 Topical corticosteroids 60 hyperprolactinemia 60 patients undergoing CABG 60 gadobutrol 60 heFH 60 gastroesophageal reflux GERD 60 PRADAXA 60 genital ulcer disease 60 glitazone 60 LEXIVA r 60 neurodevelopmental impairment 60 Univariate analysis 60 MCyR 60 decompensated heart failure 60 extrapyramidal symptoms 60 virological response 59 efavirenz EFV 59 insulin glulisine 59 Febrile neutropenia 59 salmeterol HFA MDI 59 diabetic kidney 59 psychiatric comorbidities 59 postmenopausal hormone 59 placebo dexamethasone 59 Parnate 59 Chemotherapy induced 59 FRAGMIN 59 antiandrogen 59 analgesic medications 59 CYPHER Stent 59 anemia hemoglobin 59 nondiabetic patients 59 trials RCTs 59 symptom exacerbation 59 vitamin D inadequacy 59 SRBD 59 CIMZIA ™ 59 oral anticoagulation 59 salmeterol fluticasone propionate 59 TOVIAZ 59 hypercholesterolaemia 59 moderate renal impairment 59 symptomatic aortic stenosis 59 ddI 59 linaclotide treated 59 null responder HCV 59 Sleep disturbances 59 albumin excretion rate 59 Rilonacept 59 8mg/kg 59 genotypic resistance 59 canakinumab 59 evaluating tivozanib 59 neutrophil counts 59 prospectively enrolled 59 CellCept mycophenolate mofetil 59 antiepileptics 59 squamous histology 59 Hydroxyurea 59 venlafaxine Effexor 59 TNF alpha inhibitor 59 complete cytogenetic response 59 stavudine d4T 59 Celexa citalopram 59 Diamyd r 59 BENICAR HCT 59 symptomatic intracranial 59 anticonvulsant medications 59 pulmonary dysfunction 59 alfuzosin 59 nadroparin 59 abrupt discontinuation 59 ACEIs 59 Exacerbations 59 Calcium intake 59 uncontrolled asthma 59 Subgroup analysis 59 ICD shocks 59 aripiprazole Abilify 59 tolterodine ER 59 Helicobacter pylori eradication 59 PHPT 59 % CI #.#-#.# [007] 59 HMG CoA reductase inhibitors 59 antidepressants fluoxetine 59 RISPERDAL ® 59 mycophenolate mofetil 59 Anti retroviral therapy 59 Luvox fluvoxamine 59 inhaled glucocorticoids 59 Severe Primary IGFD 59 riociguat 59 noscapine 59 hemorrhagic complications 59 VIIBRYD 59 GH deficiency 59 plasma homocysteine levels 59 oral antidiabetic medication 59 Thal Dex 59 serum lipid levels 59 moderate hepatic impairment 59 antiangiogenic therapy 59 oral FTY# 59 antirheumatic 59 thiazide 59 quetiapine Seroquel 59 BenzaClin R 59 diarrheal deaths 59 LNG IUS 59 Anticonvulsants 59 LAB CGRP 59 steroid inhalers 59 Zyban bupropion 59 CAELYX 59 T1DM 59 oral antidiabetes drugs 59 Abacavir 59 MULTAQ 59 mycophenolate 59 conventional antipsychotics 59 reproductive tract infections 59 Drug eluting stent 59 loop diuretic 59 aneurysmal subarachnoid hemorrhage 59 isolated systolic hypertension 59 IPAH 59 inhospital mortality 59 venous blood clots 59 thromboembolic complications 59 adalimumab Humira 59 zidovudine lamivudine 59 sertraline Zoloft 59 nonmelanoma skin cancers 59 glycemic variability 59 Heterozygous Familial Hypercholesterolemia 59 leucopenia 59 Oral contraceptive 59 external genital lesions 59 depressive symptom 59 coronary revascularization procedures 59 virologically 59 d4T stavudine Zerit 59 paroxetine Paxil 59 aldosterone antagonists 59 hypertension diabetes mellitus 59 PPSV# 59 SCIg 59 neonatal morbidity 59 anxiolytics 59 INVEGA ™ 59 anticholinergic medication 59 bezafibrate 59 pegylated IFN 59 DHEA supplementation 59 paricalcitol 59 Didanosine 59 prostaglandin analogues 59 non valvular atrial 59 Oropharyngeal Candidiasis 59 palivizumab 59 elevated transaminases 59 PREZISTA r 59 virological failure 59 univariate analyzes 59 HIV HCV coinfected 59 Naive Patients 59 Vitamin D insufficiency 59 virologic breakthrough 59 guideline concordant 59 probiotic supplementation 59 comorbid disorders 59 mucosal inflammation 59 metabolic dysregulation 59 achieved sustained virological 59 intravascular hemolysis 59 gonococcal 59 recurrent genital herpes 59 buprenorphine implants 59 concomitant medications 59 juvenile idiopathic arthritis JIA 59 maximally tolerated 59 DULERA 59 atrophic gastritis 59 oral Hycamtin 59 dopaminergic therapy 59 fatigue diarrhea nausea 58 d4T 58 efalizumab 58 nephrotoxicity 58 NUCYNTA ™ 58 Allergic Rhinitis 58 pioglitazone hydrochloride 58 achieved CCyR 58 hematologic parameters 58 IFN alfa 58 adenoma recurrence 58 invasive candidiasis 58 glucocorticoid induced osteoporosis 58 Velcade bortezomib 58 hematologic abnormalities 58 BARACLUDE R 58 APTIVUS R 58 VT VF 58 #mg doses [002] 58 REYATAZ ritonavir 58 oral naltrexone 58 leukotriene receptor antagonists 58 Serdolect ® 58 sitaxsentan 58 genotype 1b 58 Attention-Deficit/Hyperactivity Disorder ADHD 58 neuropsychiatric symptoms 58 CIPN 58 desvenlafaxine succinate 58 efficacy evaluable 58 nonexposed 58 seropositivity 58 chronic prostatitis chronic 58 inhospital 58 cinacalcet 58 Teriparatide 58 refractory gout 58 PRADAXA #mg 58 antenatal depression 58 Triptan 58 ZOMIG Nasal Spray 58 dose escalation phase 58 PREZISTA r arm 58 induced anemia 58 Suicidal ideation 58 Cotrimoxazole 58 ofpatients 58 anticholinergic agents 58 pyrazinamide 58 GnRH agonists 58 Natalizumab 58 anastomotic leak 58 Anti depressant 58 beta blocker therapy 58 decompensated liver disease 58 MAGE A3 ASCI 58 HAV infection 58 nonaspirin 58 postoperative infection 58 INFERGEN 58 CHD CVD 58 EDARBI 58 gastrointestinal perforations 58 biologic DMARD 58 somnolence sleepiness 58 Fasting plasma glucose 58 PLX STROKE targeting 58 allogeneic HSCT 58 Femara letrozole 58 GnRH agonist 58 atherothrombotic 58 parkinsonian symptoms 58 induced akathisia 58 dermatologic reactions 58 Telithromycin 58 INVEGA ® 58 spirometric 58 atorvastatin #mg 58 bronchodilatory 58 NOMID 58 opioid overdose 58 CLINICAL PHARMACOLOGY 58 Viread Emtriva 58 fosamprenavir 58 atherogenic dyslipidemia 58 AA Amyloidosis 58 labetalol 58 lipid lowering medication 58 overactive bladder syndrome 58 syncopal 58 coinfection 58 MS relapses 58 medication nonadherence 58 GG genotype 58 Erythropoietic therapies may 58 chronic HCV infection 58 LYSTEDA 58 hematologic toxicity 58 neutropaenia 58 pegylated interferon alpha 58 headache nasopharyngitis 58 Lantus insulin 58 chronic noncancer pain 58 Prosaptide 58 APTIVUS 58 oral hypoglycemic agent 58 Nebulized 58 tenofovir emtricitabine 58 overactive bladder OAB 58 lifetime abstainers 58 darbepoetin alfa Aranesp 58 sociodemographic characteristics 58 anal HPV 58 diabetes mellitus DM 58 Combination antiretroviral therapy 58 adverse cytogenetics 58 indapamide 58 HBeAg seroconversion 58 fluoxetine Prozac 58 antiplatelet medications 58 Serious adverse reactions 58 methotrexate monotherapy 58 atherosclerotic renal artery stenosis 58 anticholinergics 58 neurocognitive impairment 58 rosuvastatin #mg 58 Pentacel vaccine 58 low dose Iluvien 58 orofacial clefts 58 ziprasidone 58 chronic idiopathic thrombocytopenic purpura 58 Adjunctive 58 lenalidomide dexamethasone 58 Malnourishment 58 fluvastatin 58 clodronate 58 Pegylated Interferon 58 alemtuzumab treated 58 peg interferon 58 iPrEx study 58 HBeAg positive patients 58 loop diuretics 58 shorter telomere length 58 Nonadherence 58 CR nPR 58 antiandrogens 58 LRTI 58 ergot derivatives 58 Aloxi injection 58 perioperative morbidity 58 invasive aspergillosis 58 oral antidiabetic drugs 58 Flu Cy 58 Fluid retention 58 RAS blockers 58 angiotensin converting enzyme inhibitors 58 hematological parameters 58 pooled comparator 58 zoledronate 58 methylphenidate Ritalin 58 FOLFIRINOX 58 discontinued Viread 58 COMBIVIR 58 anthracycline therapy 58 Noxafil 58 BEXXAR Therapeutic Regimen 58 THALOMID 58 MenC 58 biphasic insulin aspart 58 endometrial hyperplasia 58 angiotensin receptor blockers ARBs 58 droperidol 58 % CI #.#-#.# [006] 58 QTc prolongation 58 non aspirin NSAIDs 58 antithrombotic agent 58 empiric treatment 58 malarial anemia 58 renal flares 58 Non inferiority 58 elevated LDH 58 Clostridium difficile infections 58 ARCOXIA 58 baseline A1C 58 hemorrhagic cystitis 58 PROCRIT ® 58 acid suppressive medications 58 overt nephropathy 58 serum BDNF 58 sedating antihistamine 58 adenotonsillectomy 58 Adverse effects 58 nitroprusside 58 intravenous bisphosphonates 58 NYHA functional class 58 Postoperative complications 58 Certolizumab pegol 58 vaccinees 58 Histalean TM 58 macrolide antibiotic 58 renal scarring 58 achieving PASI 58 ipratropium bromide 58 prescribed opioids 58 acute postoperative 58 virologic failures 58 perioperative complications 58 corticosteroid therapy 58 constipation nausea 58 ACTOplus met XR 58 H. pylori eradication 58 QVAR 58 resynchronization therapy 58 Peripheral edema 58 ispinesib administered 58 HBeAg 58 Combination therapy 58 Known hypersensitivity 58 frequent awakenings 58 hyperphenylalaninemia HPA due 58 CCR5 tropic HIV 58 R adefovir dipivoxil 58 antidiabetic medication 58 diastolic hypertension 58 dyslipidemic 58 fatal anaphylactic 58 shingles herpes zoster 58 long acting bronchodilator 58 hemodilution 58 mesilate 58 SGPT 58 fetal malformations 58 % CI #.#-#.# [003] 58 oral hypoglycemic 58 Suboptimal 58 sociodemographic factors 58 vWD 58 renal impairment 58 ICD implants 58 pharmacokinetic interactions 58 eszopiclone 58 serum phosphorous 58 leukotriene receptor antagonist 58 cotrimoxazole 58 chronic thromboembolic pulmonary 58 warfarin erythromycin 58 Thromboembolic 58 tolterodine 58 intensive statin therapy 57 NIH CPSI 57 thromboembolic 57 antibiotic rifaximin 57 antipsychotic prescribing 57 pimozide 57 antimicrobial prophylaxis 57 Chlamydia infection 57 serum urate 57 HBV infections 57 testosterone supplementation 57 Sustiva efavirenz 57 nucleotide analogue 57 ARIXTRA 57 Chronic Obstructive Lung 57 Lamotrigine 57 HAM D# scores 57 confusional 57 prospective multicentre 57 beta blockers ACE inhibitors 57 observational cohort 57 thiazide diuretic 57 Rheumatoid Arthritis RA 57 virologic responses 57 aged ≥ 57 RLS sufferers 57 retrograde ejaculation 57 fluoxetine paroxetine 57 VTEs 57 anemia neutropenia 57 Detrol Detrol LA 57 ano genital warts 57 ziconotide 57 ORENCIA R 57 Adjuvant chemotherapy 57 CLINICAL STUDIES 57 severe rotavirus gastroenteritis 57 ticlopidine 57 Dialysis Outcomes 57 Valtrex valacyclovir 57 MoxDuo TM IR 57 thromboprophylaxis 57 CANCIDAS 57 retransplantation 57 primary dysmenorrhoea 57 hematopoietic cancers 57 Pneumococcal vaccination 57 serum sodium levels 57 nociceptive pain 57 concurrent ITP 57 torsade de pointes 57 Oral corticosteroids 57 Amodiaquine 57 meta regression 57 SSRI citalopram 57 odds ratios ORs 57 nicardipine 57 glucocorticoid therapy 57 VLBW 57 colorectal bowel 57 lupus anticoagulant 57 #mg ATC 57 induced hepatotoxicity 57 mycophenolic acid 57 neuroleptic 57 MERLIN TIMI 57 AZT zidovudine Retrovir 57 prescribed antipsychotics 57 HIV seroprevalence 57 anti dyslipidemic 57 Aptivus 57 QTcF 57 Comorbid 57 Desmopressin 57 GI bleeds 57 ischemic cardiomyopathy 57 anticholinergic drugs 57 immune reconstitution syndrome 57 Antiretroviral therapy 57 fluvoxamine Luvox 57 ESBL producing E. coli 57 tuberculin skin testing 57 nephrotoxic drugs 57 glitazones 57 immunosuppressives 57 clot busting therapy 57 Candesartan 57 BYSTOLIC 57 albumin excretion 57 #OHD levels 57 tinidazole 57 Antiretroviral Therapy 57 inhaled corticosteroid therapy 57 typical antipsychotics 57 post herpetic neuralgia PHN 57 clevidipine 57 antiarrhythmic drug 57 MenACWY 57 receiving TNF blockers 57 C difficile infection 57 propranolol Inderal 57 myopathy rhabdomyolysis 57 Starlix 57 SJIA 57 Quetiapine 57 sargramostim 57 See WARNINGS 57 Sprycel dasatinib 57 hepatotoxicity 57 hepatic insufficiency 57 thrombocytopenia neutropenia 57 generalized edema 57 silent ischemia 57 somnolence fatigue 57 STRIDE PD 57 KRAS mutant tumors 57 Venous thromboembolism 57 persistent pulmonary hypertension 57 HIV seroconversion 57 mCRC acneform rash 57 serotonin reuptake inhibitors 57 urine albumin 57 vertigo dizziness 57 pharmacokinetic interaction 57 chronic rheumatic 57 Vimpat R 57 enalapril 57 symptom flare ups 57 comorbid psychiatric 57 seropositive patients 57 induce orthostatic hypotension 57 abnormal ejaculation 57 RoACTEMRA 57 antibody titer 57 Skin rashes 57 initiating HAART 57 vasoactive 57 ertapenem 57 Chantix Champix 57 TWYNSTA 57 acetazolamide 57 sibutramine Meridia 57 rhGH 57 potassium sparing diuretics 57 dosing frequency 57 Danazol 57 androgen deficiency 57 immuno compromised individuals 57 Hepatocellular Carcinoma HCC 57 cobiprostone 57 primidone 57 Paliperidone ER 57 viral titers 57 femoral neck fracture 57 unstable angina pectoris 57 Perindopril 57 Mycophenolate Mofetil 57 hemoglobin A1c levels 57 C1 INH deficiency 57 Juvenile Idiopathic Arthritis 57 rectal gonorrhea 57 CYP#D# genotype 57 Viread Emtriva Sustiva 57 lumbar spine BMD 57 mCRPC 57 Zeldox 57 bupropion Wellbutrin 57 SSRI prescriptions 57 ethambutol 57 sulfonylurea metformin 57 FUSILEV enhances 57 maternal morbidity 57 thiazide diuretics 57 binary restenosis 57 trastuzumab Herceptin ® 57 Skin sterol 57 LPV r 57 lamotrigine 57 cerebral vasospasm 57 virologic suppression 57 thyrotropin levels 57 umol L 57 RSV hospitalizations 57 Disease GOLD 57 multivariate analyzes 57 infliximab Remicade 57 nausea vomiting headache 57 receiving SIMPONI 57 cefepime 57 Valcyte tablets 57 Pharmacokinetic parameters 57 neutropenic patients 57 cytomegalovirus retinitis 57 antibiotic regimens 57 tipranavir 57 Generalised Anxiety Disorder 57 ICS LABA combination 57 KRAS status 57 concomitant AEDs 57 ALVESCO HFA 57 Homocysteine levels 57 subcutaneous insulin 57 glulisine 57 beta interferons 57 rufinamide 57 opioid prescriptions 57 lipid lowering therapy 57 hypoglycemic events 57 lopinavir ritonavir Kaletra 57 thiopurine 57 Intravenous immunoglobulin 57 restenosis reblockage 57 elevated bilirubin 57 thiazides 57 REBETOL combination 57 constipation predominant irritable bowel 57 ULORIC 57 PEGINTRON TM 57 neuropsychiatric adverse 57 acute rhinosinusitis 57 CIN3 57 CMV retinitis 57 MAXALT 57 nonpsychotic 57 Multivariate analyzes 57 immunosuppressive regimen 57 absolute contraindication 57 susceptible isolates 57 aromatase inhibitor AI 57 opiate dependence 57 FFNS 57 Personality disorders 57 VIRAMUNE R 57 antithrombotics 57 androgen suppression 57 neutropenic sepsis 57 VADT 57 neutropenia thrombocytopenia 57 neutropenic 57 RSD# oral 57 acute myocardial infarctions 57 mg/m2 cohort 57 boosted protease inhibitor 57 tricyclic antidepressant 57 HIV coinfection 57 Cimzia TM 57 subsyndromal 57 nonmetastatic prostate cancer 57 androgen ablation 57 zidovudine AZT 57 stable angina 57 nighttime awakenings 57 4mg/kg 57 dizziness somnolence 57 Mg Uk 57 estrogen progestin combination 57 reinfarction 57 ZYVOX 57 aprepitant